Corporate Presentation
Downloads
AiCuris Corporate Presentation, Sep_2023Downloads
AiCuris Corporate Presentation, Sep_2023
Alexander Birkmann, AiCuris Anti-infective Cures AG, Head of Research, will present the design of the ongoing Phase 3 trial and give a status update on the expanded access program at the STI & HIV 2023 World Congress 2023, 24-27 July in Chicago, USA:
"Pritelivir for the treatment of resistant HSV infections in immunocompromised patients: update on an ongoing Phase 3 trial and Early Access Program"
Meet with him at:
Session: HIV PrEP, Viral STIs
Tuesday July 25, 2023
3:30 PM – 3:45 PM
Contact
Contact"Bridging the gap from fundamental virology to new antivirals" is the topic Andreas Kühbacher, AiCuris Anti-infective Cures AG Senior Manager Innovation & Alliance, would like to discuss with you at the 8th European Congress of Virology 2023, 4-7 May in Gdansk, Poland. Meet with him at:
and learn more about our programs in the field of antiviralresearch and how you can promote your own ideas with AiCuris AiCubator.
Links
ECV 2023Contact
AiCubator ContactJoin AiCuris Anti-infective Cures AG Medical Directors, Dr. Alessandra Marini, Dr. Markus Heep and Principal Scientist, Dr. Irith Wiegand, at 33rd ECCMID conference hosted by ESCMID in Copenhagen, Denmark on April 15-18 to discuss recent advancements of Pritelivir for the treatment of HSV infections in immunocompromised patients with pre-existing drug resistances, AIC468 - a first-ever direct anti-viral to treat BKV infection, and our research projects in AMR. Please do not hesitate to reach out and meet us in person.
Links
ECCMIDContact
Business ContactConnect with AiCubator at BioVaria, Europe’s leading showcasing event for life-science technologies, 24-25 April in Munich, Germany. Schedule a meeting with Andreas Kühbacher, AiCuris Anti-infective Cures AG Senior Manager Innovation & Alliance, by contacting us to discuss opportunities to boost your own early research projects in the field of antiinfectives.
Links
BioVariaContact
AiCubator ContactThe AiCuris Anti-infective Cures AG team is looking forward to discussing recent advancements of our pivotal phase 3 trial with Pritelivir treating immunocompromised patients with resistant HSV infections and ways to promote your own programs in the field of antiviralresearch with the AiCuris AiCubator at their posters.
PosterP064: Resistance analysis in a phase 2 clinical trial with the helicase-primase inhibitor Pritelivir in immunocompromised adults with Acyclovir resistant Herpes Simplex Virus (HSV) infection
Poster365: A novel approach to bridge the gap from virology research to new antivirals https://bit.ly/3JqQC4l
Links
GfVMeet Andreas Kühbacher, AiCuris Sr. Manager Innovation & Alliance, at ICAR 2023 and visit our poster number 400 to discuss new ideas around “Bridging the gap from fundamental virology to new antivirals”. The annual main event of the International Society for Antiviral Research (ISAR) takes place from March 13-17 in Lyon, France.
Ask for a meeting by contacting us directly under aicubator@AiCuris.com.
Join the BD team of the Powerhouse of Anti-infectives, @AiCuris Anti-infective Cure AG, at the BIO-Europe Spring 2023, taking place from March 20-22 in Basel, Switzerland. Request a meeting with Igor Orshanskiy, Director Business Development via the conference partneringONE system to discuss recent developments and opportunities in the #antiinfective field: https://bit.ly/3Xw39Zj
Links
Bio Europe SpringContact
Email